Acacia’s third-quarter revenue is up compared to the same period last year—a fact primarily attributed to the number of trials in 2014 (ten versus only three in 2013)—but its trailing nine-month revenue is down. Also, despite a significant increase in revenue this quarter, Acacia’s litigation and licensing expenses dwarfed the NPE’s payments to patent holders.